These molecules possess anti-inflammatory capacity, inhibiting the NF-kB pathway, and they have been shown to reduce arterial pressure [64] and participate in the inhibition of mechanisms implicated in the generation of left ventricular hypertrophy and myocardial fibrosis [65]. Here, NFKB1 is linked to Myocardial fibrosis.